GlassScriptPhysician profile
Carlos A Rojas
NPI 1679889547
$1,346.13
in general payments reported to CMS, 2019-2025
12 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $173 · 2021: $154 · 2022: $274 · 2023: $118 · 2024: $177 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $540.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $395.80 | 2020-2023 | Claw II |
| Pfizer INC. | $359.71 | 2019-2025 | |
| Orthofix Medical, INC. | $200.00 | 2022 | |
| Urgo Medical North America, LLC | $119.45 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Paragon 28, INC. | $57.02 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $51.02 | 2019-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $48.39 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $26.41 | 2025 | Verquvo |
| Biocomposites INC | $25.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.84 | 2019 | |
| Baxter Healthcare | $20.77 | 2019 | |
| Novo Nordisk INC | $17.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.